European Thrombosis and Haemostasis Alliance Elects Prof. Ingrid Pabinger-Fasching as Chair
The European Thrombosis and Haemostasis Alliance (ETHA) has elected Prof. Ingrid Pabinger-Fasching as the new chair of the Alliance for a term of two years.
Pabinger-Fasching is Professor of Haemostaseology and Vice-Head of the Clinical Division of Haematology and Haemostaseology at the Medical University of Vienna, Austria. She takes over the role from Prof. Anna Falanga, Professor of Haematology at University of Milan Bicocca, and Chief of the Department of Immunohaematology and Transfusion Medicine and the Thrombosis and Haemostasis Centre at the Hospital Papa Giovanni XXIII in Bergamo, Italy.
“I am honoured to take on this position and I am looking forward to working with our Alliance members to advance the European commitment to research on causes and prevention of thrombosis. I hope to build on the fantastic work by Dr. Falanga, whose leadership and expertise has been instrumental in the Alliance’s work on cancer-associated thrombosis,” said Prof. Pabinger-Fasching.
An eminent academic, Prof. Pabinger-Fasching has published over 430 articles for peer-reviewed journals and acted as principal investigator for over 50 clinical trials in her career. Her fields of expertise include hereditary and acquired thrombosis risk factors, cancer-associated thrombosis, haemophilia and acquired haemorrhagic diathesis, immune thrombocytopenia and specific coagulation problems in critically ill patients.
Prof. Pabinger-Fasching is also a leader in her field of clinical practice, haemostaseology. Since 1997 she has directed the haemostaseology outpatient department for adults at the Vienna General Hospital, where she is responsible for the diagnosis and treatment of patients with thromboembolic and bleeding disorders.
In addition to her academic and clinical work, Prof. Pabinger-Fasching has also held chair roles in several international and national scientific societies throughout her career, including the German, Austrian and Swiss Society of Thrombosis and Haemostasis (GTH) and the ETHA’s parent organisation, the International Society on Thrombosis and Hemostasis (ISTH).
Jeffrey Weitz, ISTH President, said, “As a practising clinician, an accomplished academic and a former ISTH President, Prof. Pabinger-Fasching is expertly qualified to advocate for the thrombosis and haemostasis community at the European level. We look forward to collaborating once again and wish her every success in this role.”
About the ETHA
The European Thrombosis and Haemostasis Alliance (ETHA) is made up of eminent clinicians and researchers from European national and international societies representing those working in the field of thrombotic and bleeding disorders. We have come together to give the European thrombosis and haemostasis community an allied voice and provide input to EU health and patient safety strategies; make recommendations on EU research programme funding and encourage sharing and adoption of best practices in the treatment and prevention of thrombotic and bleeding disorders across Member States.
For further information, please contact: firstname.lastname@example.org or Sture Alne / ETHA secretariat on +32 488568225.